OKYO Pharma CEO Announces First Dosing in Phase 2 Trial for OK-101 to Treat Neuropathic Corneal Pain

By Proactive Investors / October 24, 2024 / www.youtube.com / Article Link


OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share news the company is reporting the first patient has ...

Recent News

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows

July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok